John Leferovich

3.6k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

John Leferovich is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, John Leferovich has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Genetics. Recurrent topics in John Leferovich's work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). John Leferovich is often cited by papers focused on Virus-based gene therapy research (8 papers), CAR-T cell therapy research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). John Leferovich collaborates with scholars based in United States. John Leferovich's co-authors include Vladimir R. Muzykantov, Silvia Muro, Ellen Heber‐Katz, Khamilia Bedelbaeva, Boris A. Tikunov, Sanford Levine, Larry R. Kaiser, Edward H. Schuchman, Carmen Garnacho and Christine Gajewski and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

John Leferovich

36 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid manufacturing of non-activated potent CAR T cells

2022 184 citations Saba Ghassemi, Joseph S. Durgin et al. profile →

Peers

Countries citing papers authored by John Leferovich

Since Specialization

Citations

This map shows the geographic impact of John Leferovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Leferovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Leferovich more than expected).

Fields of papers citing papers by John Leferovich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Leferovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Leferovich. The network helps show where John Leferovich may publish in the future.

Co-authorship network of co-authors of John Leferovich

This figure shows the co-authorship network connecting the top 25 collaborators of John Leferovich. A scholar is included among the top collaborators of John Leferovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Leferovich. John Leferovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	F77 antigen is a promising target for adoptive T cell therapy of prostate cancer 2023 ·Biochemical and Biophysical Research Communications ·(unknown), Selene Nuñez-Cruz, John Leferovich, (unknown), Atrish Bagchi, Michael C. Milone, Mark I. Greene	6
2	Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase 2021 ·Molecular Therapy ·Joseph S. Durgin, Radhika Thokala, Lexus R. Johnson, (unknown), John Leferovich, Vijay Bhoj, Saba Ghassemi, Michael C. Milone, Zev A. Binder, Donald M. O’Rourke, Roddy S. O’Connor	21
3	Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy 2020 ·Clinical Cancer Research ·Eduardo Huarte, Roddy S. O’Connor, Michael T. Peel, Selene Nuñez-Cruz, John Leferovich, Ashish Juvekar, (unknown), Lisa Truong, Taisheng Huang, Ahmad Naim, Michael C. Milone, Paul Smith	67
4	Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design 2020 ·Molecular Therapy — Methods & Clinical Development ·Saba Ghassemi, Francisco J. Martinez-Becerra, Аlyssa M. Master, Sarah A. Richman, (unknown), John Leferovich, (unknown), Juan Carlos García‐Cañaveras, (unknown), (unknown), (unknown), Joshua D. Rabinowitz, Michael C. Milone, Carl H. June, Roddy S. O’Connor	52
5	Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells 2018 ·Cancer Immunology Research ·Saba Ghassemi, Selene Nuñez-Cruz, Roddy S. O’Connor, Joseph A. Fraietta, Prachi Patel, John Scholler, David M. Barrett, Stefan Lundh, Megan M. Davis, Felipe Bedoya, Changfeng Zhang, John Leferovich, Simon F. Lacey, Bruce L. Levine, Stephan A. Grupp, Carl H. June, J. Joseph Melenhorst, Michael C. Milone	212
6	Lack of p21 expression links cell cycle control and appendage regeneration in mice 2010 ·Proceedings of the National Academy of Sciences ·Khamilia Bedelbaeva, Andrew R. Snyder, Dmitri Gourevitch, Lise Clark, Xiangming Zhang, John Leferovich, James M. Cheverud, Paul M. Lieberman, Ellen Heber‐Katz	157
7	Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers 2010 ·Journal of Controlled Release ·(unknown), Tridib Kumar Bhowmick, John Leferovich, Bharat Burman, (unknown), Vladimir R. Muzykantov, David M. Eckmann, Silvia Muro	66
8	Dynamic changes after murine digit amputation: The MRL mouse digit shows waves of tissue remodeling, growth, and apoptosis 2009 ·Wound Repair and Regeneration ·(unknown), Lise Clark, Khamilia Bedelbaeva, John Leferovich, Ellen Heber‐Katz	36
9	Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers 2008 ·Molecular Therapy ·Silvia Muro, Carmen Garnacho, Julie A. Champion, John Leferovich, Christine Gajewski, Edward H. Schuchman, Samir Mitragotri, Vladimir R. Muzykantov	467
10	Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Carmen Garnacho, Rajwinder Dhami, Eric Simone, Thomas D. Dziubla, John Leferovich, Edward H. Schuchman, Vladimir R. Muzykantov, Silvia Muro	87
11	Conjecture: Can Continuous Regeneration Lead to Immortality? Studies in the MRL Mouse 2006 ·Rejuvenation Research ·Ellen Heber‐Katz, John Leferovich, Khamilia Bedelbaeva, Dmitri Gourevitch, Lise Clark	12
12	The MRL Mouse Heart Healing Response Shows Donor Dominance in Allogeneic Fetal Liver Chimeric Mice 2004 ·Cloning and Stem Cells ·Khamilia Bedelbaeva, Dmitri Gourevitch, Lise Clark, Pan Chen, John Leferovich, Ellen Heber‐Katz	15
13	The scarless heart 2002 ·Seminars in Cell and Developmental Biology ·John Leferovich, Ellen Heber‐Katz	19
14	The induction of skeletal muscle hypertrophy by a ski transgene is promoter-dependent 2000 ·Gene ·P Sutrave, John Leferovich, Alan M. Kelly, Stephen H. Hughes	12
15	Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector 1999 ·Nature Medicine ·James P. Greelish, Leonard T. Su, Edward B. Lankford, James M. Burkman, Haiyan Chen, (unknown), (unknown), Philippe Desjardins, Marilyn A. Mitchell, (unknown), John Leferovich, Guang Ping Gao, Rita J. Balice‐Gordon, James M. Wilson, Hansell H. Stedman	171
16	Cellular Adaptations in the Diaphragm in Chronic Obstructive Pulmonary Disease 1997 ·New England Journal of Medicine ·Sanford Levine, Larry R. Kaiser, John Leferovich, Boris A. Tikunov	293
17	Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy 1996 ·Nature Genetics ·Sita Reddy, Daniel B. Smith, Mark M. Rich, John Leferovich, (unknown), Brigid M. Davis, Khoa D. Tran, Helen Rayburn, Roderick T. Bronson, Didier Cros, Rita J. Balice‐Gordon, David E. Housman	254
18	Selective expression of aski transgene affects IIb fast muscles and skeletal structure 1996 ·Developmental Dynamics ·(unknown), John Leferovich, (unknown), Stephen H. Hughes	18
19	Fibre types inLimulus telson muscles: morphology and histochemistry 1989 ·Journal of Muscle Research and Cell Motility ·Rhea J. C. Levine, Sandra Davidheiser, (unknown), Robert W. Kensler, John Leferovich, R. E. Davies	7
20	Neuromuscular relationships during claw regeneration in Californian snapping shrimp 1984 ·Journal of Experimental Zoology ·Philip J. Stephens, John Leferovich	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact